Connection

Anjan Trikha to Treatment Outcome

Back to Details
This is a "connection" page, showing publications Anjan Trikha has written about Treatment Outcome.
Anjan Trikha
Connection Strength
0.015
Treatment Outcome
  1. A two-arm, randomized, controlled, multi-centric, open-label phase-2 study to evaluate the efficacy and safety of Itolizumab in moderate to severe ARDS patients due to COVID-19. Expert Opin Biol Ther. 2021 05; 21(5):675-686.
    View in: PubMed
    Score: 0.008
  2. Perioperative antiemetic efficacy of dexamethasone versus 5-HT3 receptor antagonists: a meta-analysis and trial sequential analysis of randomized controlled trials. Eur J Clin Pharmacol. 2018 Oct; 74(10):1201-1214.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.